FDA Enforcement Class II Terminated

Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.

Recall: Z-1338-2019 · Reported May 22, 2019

Enforcement

Recall Number
Z-1338-2019
Event ID
82653
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Integra Limited
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 22, 2019
Initiation Date
March 31, 2019
Classification Date
May 15, 2019
Termination Date
May 7, 2020
Address
311 Enterprise Dr, Plainsboro, NJ, 08536-3344, United States

Description

Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.

Reason

Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months

Code Info

Lot Code: 2991332

Distribution

Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil

Quantity

274 units